Tweet
Press News
<img alt="" height="1" width="1" />
Duke backs safety findings from controversial Avandia trial
Reuters
By Ransdell Pierson. June 3 | Mon Jun 3, 2013 5:12pm EDT. June 3 (Reuters) - An independent analysis of a controversial clinical trial appears to back the safety of GlaxoSmithKline Plc's diabetes drug Avandia, U.S. regulators said on Monday, although ...
FDA Scientists Find No Serious Misconduct in Avandia TestsNew York Times (blog)
FDA Reconsiders Curbs on AvandiaWall Street Journal- India
With One Big Exception FDA Reviewers Back More Benign View Of Avandia TrialForbes
MedPage Today -San Francisco Chronicle
all 46 news articles »
More...